Skip to content
Screener

Ardelyx ARDX Business Segments — Total revenues

Similar metrics at other companies

nCino, Inc. logo
NCNOReportable Segment — Total revenues
$159.41M+10.6%
BJ's Wholesale Club Holdings, Inc. logo
BJReportable Segment — Total revenues
$5.66B+9.9%
Calix logo
CALXReportable Segment — Total revenues
$293.33M+21.3%
CuriosityStream logo
CURIReportable Segment — Total revenues
$15.16M+0.5%
comScore logo
SCORReportable Segment — Total revenues
$85.32M-0.5%
Neurocrine Biosciences logo
NBIXReportable Segment — Total revenues
$814.5M+42.2%

Other financials

Income statement

See full
Revenue$120.9M+23.8%
Gross profit$115.1M+35.0%
Operating income-$12.4M+13.7%
Net income-$16.7M+12.4%
EPS (diluted)-$0.07+12.5%

Balance sheet

See full
Cash & equivalents$97.2M+7.9%
Total debt$256.2M+24.0%
Total equity$149.0M+6.8%
Total assets$575.9M+23.4%

Cash flow

See full
Operating cash flow-$6.4M+74.7%
CapEx$13.0K-98.0%
Free cash flow-$6.4M+75.3%

Valuation

See full
Market cap$1.2B-4.0%
Enterprise value$1.36B-0.6%
P/S2.7×-0.6×

Profitability

See full
Gross margin94.4%+9.6pp
Operating margin-25.4%
Net margin-12.4%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.7×+0.2×
Current ratio3.3×-1.0×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Ardelyx’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001437402-26-000044
(in thousands)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Revenues
Product sales, net$118,129$90,077$211,502$157,891
Other revenues(1)2,7487,5853,84813,885
Total revenues120,87797,662215,350171,776
Less
Cost of product sales(2)3,6893,2456,5645,585
Other cost of revenue(3)2,0709,1584,00619,121
Research and development(4)23,19513,25140,78124,586

Item 1. Financial Statements (Unaudited)

FAQ

What is Ardelyx's business segments — total revenues?
Ardelyx (ARDX) reported business segments — total revenues of $120.88M in Q2 2026.
How has Ardelyx's business segments — total revenues changed year-over-year?
Ardelyx's business segments — total revenues increased by 23.8% year-over-year, from $97.66M to $120.88M.
What is the long-term trend for Ardelyx's business segments — total revenues?
Over 3 years (2022 to 2025), Ardelyx's business segments — total revenues has grown at a 98.4% compound annual growth rate (CAGR), from $52.16M to $407.32M.
What does business segments — total revenues mean?
Represents the total gross revenue generated by the company's primary business segment from the sale of pharmaceutical products and services. This figure reflects the market adoption and commercial success of the company's therapeutic portfolio. It serves as a key indicator of top-line growth and the effectiveness of commercialization strategies.

Ask your AI about Ardelyx's business segments — total revenues.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude